Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001857474 | SCV002169067 | pathogenic | not provided | 2024-12-26 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 255 of the ABCA4 protein (p.Arg255Cys). This variant is present in population databases (rs62645952, gnomAD 0.1%). This missense change has been observed in individual(s) with cone-rod dystrophy and/or Stargardt disease (PMID: 12515255, 33090715). ClinVar contains an entry for this variant (Variation ID: 143077). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt ABCA4 protein function with a positive predictive value of 95%. This variant disrupts the p.Arg255 amino acid residue in ABCA4. Other variant(s) that disrupt this residue have been observed in individuals with ABCA4-related conditions (PMID: 32531858), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. |
Dept Of Ophthalmology, |
RCV003888541 | SCV004706705 | uncertain significance | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Juno Genomics, |
RCV004796035 | SCV005416050 | uncertain significance | Severe early-childhood-onset retinal dystrophy | criteria provided, single submitter | clinical testing | PM2_Supporting+PM3+PP4 | |
Department of Ophthalmology and Visual Sciences Kyoto University | RCV000132594 | SCV000172541 | pathogenic | Cone-rod dystrophy 3 | no assertion criteria provided | not provided | Converted during submission to Pathogenic. |